Détail de la notice
Titre du Document
Towards evidence based medicine for paediatricians
Auteur(s)
PHILLIPS Bob ; WINCKWORTH Lucinda ; AYAT Rania ; ...
Résumé
If you were offered a choice of drugs to treat an ailment you were suffering from, and you'd asked about how effective they were (and there's a huge chunk of the population who wouldn't, and would be happy to just do as they were told), then what information would you like? How much information do you want to know? "It works better than the previous treatments", or a more mathematical estimate? Would you prefer to be told "For every ten people I give this drug to, one will benefit?", or "Taking the drug improves success rates by 10%", or perhaps "Taking the drug will double your chances of success"? As you have no doubt figured out, the above statements all refer to the same underlying difference of treatment success in 20% of patients versus 10% in the comparison group. The statements refer to the "number needed to treat", the "absolute risk reduction" and the relative risk. Their "truth" may be actually the same, but the perception of them is strikingly different: the majority of people choose the drug that doubles the success rate. Relative risks are almost always chosen over descriptions of absolute improvement, and this is not limited to the "general population" but applies to healthcare professionals too. So how can we use this? We can remember it when we're being "sold at" by drug reps. We can use it when we're selling ideas to patients and families ("But the medicine is going to double the chance of success!"). And we can also use it, with care, when we're discussing
Editeur
BMJ
Identifiant
ISSN : 0003-9888 CODEN : ADCHAK
Source
Archives of disease in childhood A. 2009, vol. 94, n° 9, pp. 736-743 [8 pages]
Langue
Anglais
Pour les membres de la communauté du CNRS, ce document est autorisé à la reproduction à titre gratuit.
Pour les membres des communautés hors CNRS, la reproduction de ce document à titre onéreux sera fournie sous réserve d’autorisation du Centre Français d’exploitation du droit de Copie.

Pour bénéficier de nos services (strictement destinés aux membres de la communauté CNRS (Centre National de la Recherche Scientifique), de l'ESR français (Enseignement Supérieur et Recherche), et du secteur public français & étranger) :